The results indicated that SMAD9, CASP3, H2-DMB2, MAPK1, MAPK3, C3, CYP4A12A, CYP4A12B, CD36, PPARG, and IL-10 maybe potential targets of Dapagliflozin in DN. The gene discussed is C3; the disease is liver dysplastic nodule.